Abstract
The routine management of acute myocardial infarction was revolutionized in the 1980s by the widespread introduction into clinical practice of safe and effective forms of reperfusion therapy. The central importance of reperfusion in any strategy for limiting infarct size has long been recognized in experimental studies. It was not, however, until several large clinical trials had demonstrated that thrombolysis could both achieve reperfusion and, more importantly, reduce mortality1,2 that such techniques became widely used. More recent studies have shown that direct balloon angioplasty of the acutely occluded coronary vessel has been shown to be even more effective,3–5 presumably due to reperfusion being achieved more rapidly and more reliably than with thrombolysis. Despite these major advances ischemic heart disease, in its various forms, is still responsible for more deaths in the developed world than any other disease process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
GISSI. Long term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987; 2: 871–874.
ISIS-2 collaborative study group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither amongst 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349–360.
Gibbons RJ, Holmes DR, Reeder GS et al. Immediate angioplasty corn-pared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685–691.
Grines CI, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673–679.
Zijlstra F, de Boer MJ, Hoorntje JCA et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–684.
EMERAS Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993; 342: 767–772.
Late Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759–766.
Yusuf S, Peto R, Lewis J et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–371.
Jennings RA, Reimer KA. Effect of beta-adrenergic blockade on acute myocardial ischemic injury. In: Gross F ed. Modulation of sympathetic tone in the treatment of cardiovascular diseases. Berne: Hans Huber, 1979: 103–114.
Rossi P, Yusuf S, Ramsdale D et al. Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. Br Med J 1983; 293: 506–510.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124–1136.
Schott RJ, Rohmann S, Braun ER et al. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133–1142.
Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991; 84: 341–349.
Li YW, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992; 123: 346–353.
Ovize M, Kloner R, Przyklenk K. Preconditioning and myocardial contractile function. In: Przyklenk K, Kloner R, Yellon D eds. Ischemic preconditioning: the concept of endogenous cardioprotection. Massachusetts: Kulwer Academic Publishers 1994: 41–60.
Ovize M, Pryzklenk K, Hale SL et al. Preconditioning does not attenuate myocardial stunning. Circulation 1992; 85: 2247–2254.
Lawson CS, Coltart DJ, Hearse DJ. `Dose’-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemiainduced arrhythmias in rat hearts. J Mol Cell Cardiol 1993; 25: 1391–1402.
Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusioninduced arrhythmias. Am J Physiol 1987; 253: H1470 - H1476.
Vegh A, Komoro S, Szekeres L et al. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 1992; 26: 487–495.
Murry CE, Jennings RB, Reimer KA. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913–931.
Walker DM, Marber MS, Walker JM et al. Preconditioning in isolated superfused rabbit papillary muscles. Am J Physiol 1994; 266: H1534 - H1540.
Walker DM, Walker JM, Pattison C et al. Preconditioning protects isolated human muscle. Circulation 1993; 88 (Suppl I): 138 (Abstract).
Ikonomidis JS, Tumiati LC, Mickle DAG et al. Preconditioning protects human cardiac myocytes from ischemic inury. Circulation 1993; 88 (Suppl I): I - 570 (Abstract).
Alonzo AM, Simon AB, Feinleib M. Prodromata of myocardial infarction and sudden death. Circulation 1975; 52: 1056–1061.
Davies MJ, Thomas AC, Knapman PA et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischaemic cardiac death. Circulation 1986; 73: 418–423.
Ovize M, Kloner RA, Hale SL et al. Coronary cyclic flow variations “precondition” ischemic myocardium. Circulation 1992; 85: 779–789.
Matsuda Y, Ogawa H, Moritini K et al. Effect of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction. Am Heart J 1984; 108: 955–958.
Hirai T, Fujita M, Yamanishi K et al. Significance of preinfarction angina for the preservation of left ventricular function in acute myocardial infarction. Am Heart J 1992; 124: 19–24.
Muller DW, Topol EJ, Califf RM et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 1990; 119: 224–231.
Ottani F, Galvani M, Ferrini D et al. Ischemic preconditioning: prodromal angina limits myocardial infarct size. J Am Coll Cardiol 1993; 21: 149A (Abstract).
Ottani F, Galvani M, Ferrini D et al. Prodromal angina limits infarct size. A role of ischemic precoditioning. Circulation 1995; 91: 291–297.
Barbash GI, White HD, Modan M et al. Antecedent angina pectoris predicts a worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. J Am Coll Cardiol 1992; 20: 36–41.
Kloner RA, Shook T, Przyklenk K et al. Previous angina alters in-hospital outcome in TIMI-4. A clinical correlate to preconditioning? Circulation 1995; 91: 37–47.
Heibig J, Bolli R, Harris S. Initial coronary occlusion improves tolerance to subsequent prolonged balloon inflation. Cathet Cardiovasc Diagn 1989; 16: 99–102.
Deutsch E, Berger M, Kussmaul WG et al. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic and metabolic features. Circulation 1990; 82: 2044–2051.
Oldroyd KG, Paterson JG, Rumley AG et al. Coronary venous lipid peroxide concentrations after coronary angioplasty: correlation with biochemical and electrocardiographic evidence of myocardial ischaemia. Br Heart J 1992; 68: 43–47.
Ovize M, Pryzklenk K, Kloner RA. Preconditioning with one very brief episode of ischemia does not enhance recovery of function in peri-infarct tissue. Eu Heart J 1992; 13 (Suppl): 438 (Abstract).
Cribrier A, Korsatz L, Koning R et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. JACC 1992; 20: 578–586.
Hausmann D, Lichtlen PR, Nikutta P et al. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiol Int 1991; 8: 385–398.
Rocco MB, Barry J, Campbell S et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75: 395–400.
MacAlpin RN, ‘Cactus AA. Adaptation to exercise in angina pectoris. Circulation 1966; 33: 183–201.
Selwyn AP, Raby K, Vita JA et al. Diurnal rhythms and clinical events in coronary artery disease. Postgrad Med J 1991; 67 (Suppl V): S44–47.
Williams DO, Bass TA, Gewirtz H et al. Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon. Circulation 1985; 71: 687–692.
Okazaki Y, Kazuhisa K, Sato H et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. JACC 1993; 21: 1597–1604.
Jaffe MD, Quinn NK. Warm-up phenomenon in angina pectoris. Lancet 1980; 2: 934–936.
Kitakaze M, Hori M, Takashima S et al. Increased 5’-nucleotidase activity caused by protein kinase C enhances adenosine production in hypoxic cardiomyocytes of rats. Circulation 1991; 84 (Suppl II): 620 (Abstract).
Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993; 342: 276–277.
Kida M, Fujiwara H, Ishida M et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991; 84: 2495–2503.
Miyamae M, Fujiwara H, Kida M et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation 1993; 88: 223–234.
Pasternak R, Braunwald E, BE S. Acute myocardial infarction. In: Braunwald E ed. Heart Disease. Philadelphia: WB Saunders 1988: 1222–1313.
Lawson CS, Downey JM. Ischaemic preconditioning: state of the art myocardial protection. Cardiovasc Res 1993; 27: 542–550.
Kuzuya S, Hoshida S, Yamashita N et al. Delayed effects of sublethal ischemia on the aquisition of tolerance to ischemia. Circ Res 1993; 72: 1293–1299.
Marber MS, Latchman DS, Walker JM et al. Cardiac stress protein elevation 24 hours after brief ischaemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264–1272.
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lawson, C.S. (1996). Preconditioning in the Human Heart: Fact or Fantasy?. In: Myocardial Preconditioning. Medical Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22206-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-22206-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22208-9
Online ISBN: 978-3-662-22206-5
eBook Packages: Springer Book Archive